Shanafelt Armen 4
4 · Surface Oncology, Inc. · Filed Oct 3, 2019
Insider Transaction Report
Form 4
Shanafelt Armen
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2019-10-01+16,531→ 16,531 totalExercise: $1.17Exp: 2029-10-01→ Common Stock (16,531 underlying)
Footnotes (1)
- [F1]This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer and committee fees of $11,875 which would have been paid quarterly. This option shall vest in full on December 31, 2019.